Banner for leaf pages 2

Quazepam (Doral)

Also known as Doral

Quazepam (marketed under brand names Doral, Dormalin) is a benzodiazepine derivative drug developed by the Schering Corporation in the 1970s. Quazepam is indicated for the treatment of insomnia including sleep induction and sleep maintenance. Quazepam induces impairment of motor function and has hypnotic and anticonvulsant properties with less overdose potential than other benzodiazepines. Quazepam is an effective hypnotic which induces and maintains sleep without disruption of the sleep architecture. Quazepam is a trifluoroethyl type of benzodiazepine. Quazepam is unique amongst benzodiazepines in that it selectively targets the GABAA a1 sub unit receptors which are responsible for inducing sleep. Its mechanism of action is very similar to zolpidem and zaleplon in its pharmacology and can successfully substitute for zolpidem and zaleplon in animal studies. Quazepam is manufactured by the pharmaceutical corporation Schering-Plough.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed quazepam to treat blastomycosis, rabies, west nile virus, and pick disease.

What drug interactions are known?

Do not take quazepam if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...